Crypto Updates

Critical Insights From Sangamo Therapeutics Analyst Ratings: What You Need To Know

Veteran Trader Peter Brandt Asks Macro Guru If Bitcoin Bull Has Finally Awoken From Deep Slumber

In the preceding three months, 4 analysts have released ratings for Sangamo Therapeutics (NASDAQ:SGMO), presenting a wide array of perspectives from bullish to bearish.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 3 0 1 0 0
Last 30D 1 0 0 0 0
1M Ago 0 0 0 0 0
2M Ago 1 0 0 0 0
3M Ago 1 0 1 0 0

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $3.75, a high estimate of $5.00, and a low estimate of $2.00. Marking an increase of 25.0%, the current average surpasses the previous average price target of $3.00.

Analyzing Analyst Ratings: A Detailed Breakdown

In examining recent analyst actions, we gain insights into how financial experts perceive Sangamo Therapeutics. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Patrick Trucchio HC Wainwright & Co. Maintains Buy $5.00
Patrick Trucchio HC Wainwright & Co. Raises Buy $5.00 $3.00
Luca Issi RBC Capital Maintains Sector Perform $2.00
Patrick Trucchio HC Wainwright & Co. Maintains Buy $3.00 $3.00

Key Insights:

Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they ‘Maintain’, ‘Raise’, or ‘Lower’ their stance, it signifies their response to recent developments related to Sangamo Therapeutics. This offers insight into analysts’ perspectives on the current state of the company.
Rating: Gaining insights, analysts provide qualitative assessments, ranging from ‘Outperform’ to ‘Underperform’. These ratings reflect expectations for the relative performance of Sangamo Therapeutics compared to the broader market.
Price Targets: Analysts set price targets as an estimate of a stock’s future value. Comparing the current and prior price targets provides insight into how analysts’ expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock’s potential future performance.

Navigating through these analyst…

Click Here to Read the Full Original Article at Cryptocurrencies Feed…